Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Biorxiv : the Preprint Server for Biology
|
September 11, 2024
Neuroendocrine Prostate Cancer Drivers SOX2 and BRN2 Confer Differential Responses to Imipridones ONC201, ONC206, and ONC212 in Prostate Cancer Cell Lines
Connor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
American Journal of Translational Research
|
January 17, 2025
Neuroendocrine prostate cancer drivers SOX2 and BRN2 confer differential responses to imipridones ONC201, ONC206, and ONC212 in prostate cancer cell lines
Connor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
Cancers
|
February 13, 2025
Heterogeneity in Cancer
William J MacDonald, Connor Purcell, Maximilian Pinho-Schwermann, et al.
American Journal of Cancer Research
|
October 17, 2024
Synergistic anti-tumor activity, reduced pERK, and immuno-stimulatory cytokine profiles with 5-FU or ONC212 plus KRAS G12D inhibitor MRTX1133 in CRC and pancreatic cancer cells independent of G12D mutation
Vida Tajiknia, Maximilian Pinho-Schwermann, Praveen R Srinivasan, et al.
American Journal of Cancer Research
|
January 12, 2026
Inhibition of ITGB6 stimulates potent anti-tumor responses in immunocompetent mouse models of head and neck squamous cell carcinoma and pancreatic adenocarcinoma
William J MacDonald, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer
Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.
International Journal of Molecular Sciences
|
July 14, 2023
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer
Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.
The Journal of Clinical Investigation
|
July 15, 2025
Corrigendum to Targeting apoptotic pathways for cancer therapy
Xiaobing Tian, Praveen R Srinivasan, Vida Tajiknia, et al.
The Journal of Clinical Investigation
|
July 15, 2024
Targeting apoptotic pathways for cancer therapy
Xiaobing Tian, Praveen R Srinivasan, Vida Tajiknia, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Biorxiv : the Preprint Server for Biology
|
September 11, 2024
Neuroendocrine Prostate Cancer Drivers SOX2 and BRN2 Confer Differential Responses to Imipridones ONC201, ONC206, and ONC212 in Prostate Cancer Cell Lines
Connor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
American Journal of Translational Research
|
January 17, 2025
Neuroendocrine prostate cancer drivers SOX2 and BRN2 confer differential responses to imipridones ONC201, ONC206, and ONC212 in prostate cancer cell lines
Connor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
Cancers
|
February 13, 2025
Heterogeneity in Cancer
William J MacDonald, Connor Purcell, Maximilian Pinho-Schwermann, et al.
American Journal of Cancer Research
|
October 17, 2024
Synergistic anti-tumor activity, reduced pERK, and immuno-stimulatory cytokine profiles with 5-FU or ONC212 plus KRAS G12D inhibitor MRTX1133 in CRC and pancreatic cancer cells independent of G12D mutation
Vida Tajiknia, Maximilian Pinho-Schwermann, Praveen R Srinivasan, et al.
American Journal of Cancer Research
|
January 12, 2026
Inhibition of ITGB6 stimulates potent anti-tumor responses in immunocompetent mouse models of head and neck squamous cell carcinoma and pancreatic adenocarcinoma
William J MacDonald, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer
Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.
International Journal of Molecular Sciences
|
July 14, 2023
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer
Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.
The Journal of Clinical Investigation
|
July 15, 2025
Corrigendum to Targeting apoptotic pathways for cancer therapy
Xiaobing Tian, Praveen R Srinivasan, Vida Tajiknia, et al.
The Journal of Clinical Investigation
|
July 15, 2024
Targeting apoptotic pathways for cancer therapy
Xiaobing Tian, Praveen R Srinivasan, Vida Tajiknia, et al.
Page
of 1